Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Cancers|June 24, 2022
Molecular Characterization of Cancer Associated Fibroblasts in Prostate CancerGiovanni Vitale, Michele Caraglia, Volker Jung, et al.
Journal of Clinical Medicine|April 26, 2025
Severe Hemodynamic Instability in a Young Pregnant Woman with Massive Pericardial Effusion and Pulmonary Embolism Secondary to Primary Mediastinal Non-Hodgkin's LymphomaGiuseppe Neri, Jessica Ielapi, Vincenzo Bosco, et al.
British Journal of Haematology|November 14, 2023
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphomaDaniele Caracciolo, Nicoletta Polerà, Beatrice Belmonte, et al.
Hematological Oncology|March 16, 2026
UMG1 Defines a Targetable Subset of T-Cell Lymphomas and Enables Precision Immunotherapy With a First-in-Class CD3ε Bispecific EngagerDaniele Caracciolo, Carlo Gentile, Sara Squillacioti, et al.
Journal of Hematology & Oncology|March 23, 2019
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myelomaMaria Cucè, Maria Eugenia Gallo Cantafio, Maria Anna Siciliano, et al.
Critical Reviews in Oncology/Hematology|August 9, 2021
The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific SocietiesAntonio Russo, Lorena Incorvaia, Umberto Malapelle, et al.
Oncology Letters|January 23, 2020
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using NivolumabValerio Nardone, Paolo Tini, Pierpaolo Pastina, et al.
Frontiers in Oncology|October 3, 2022
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approachAntonella Fameli, Valerio Nardone, Mojtaba Shekarkar Azgomi, et al.
Journal of Thoracic Disease|December 10, 2017
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patientsPierpaolo Pastina, Valerio Nardone, Stefania Croci, et al.
Cancer Biology & Therapy|October 30, 2016
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapseValerio Nardone, Cirino Botta, Michele Caraglia, et al.
Pageof 20